Belotendos, Baby Girl -.

HRN: 29-32-03  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2026
07/23/2026
IV
45mg
Q24
PSNB
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: